ClinicalTrials.gg
RecruitingNCT07800247Egyptian SCDUpdated Sep 2, 2026

Hemoglobin Disorders in Egypt: Sickle Cell Disease Ain Shams University Institutional Registry

An observational study in Sickle Cell Disease (SCD), sponsored by Ain Shams University. Recruiting at 2 sites in Egypt. Open to participants aged Up to 39 Years. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Ain Shams University · Observational

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
400
Ages
Up to 39 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 33 studies in Anemia, Sickle Cell with a site in Egypt — 9 open to participants now, 10 under way, 3 of them phase 3. Anemia, Sickle Cell · Egypt.

Started
2024
with 2 others
Observational
4 of 33
4 open now
Registered
31st of 33
by date
Lead sponsor
5 of 33
Ain Shams University

Among the 33 studies in Anemia, Sickle Cell with a site in Egypt, this one is one of 3 that started in 2024, is one of 4 observational ones, and was the 31st registered.

Anemia, Sickle Cell

1,134 studies on the registry are indexed under Anemia, Sickle Cell; 238 are open to participants now.

Browse Anemia, Sickle Cell studies →

Open to participants now

9 of the 33 studies in Anemia, Sickle Cell with a site in Egypt are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 177 Anemia, Sickle Cell studies recruiting now, 64 (36%) set no upper age limit and 97 (55%) stop at 75 or younger; 127 take children under 18; 29 take healthy volunteers.

This study: Up to 39 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 33 studies in Anemia, Sickle Cell with a site in Egypt, or all of them as a file.
02

Study summary

This is a retrospective descriptive study to create an institutional registry that will continue as a prospective follow-up non-intervention study that will be carried out at Hematology Oncology and BMT Department, Children's Hospital, Ain-Shams University, Cairo, Egypt.

03

Conditions studied

  • Sickle Cell Disease (SCD)

Browse trials for

Keywords

  • Hemoglobin
04

Who can participate

Ages eligible
Up to 39 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

children, adolescents and young adults with sickle cell disease who were following at Hematology Oncology and BMT Unit, Children's Hospital, Ain Shams University from the initiation of clinic in 1975 till 01 Jan 2027.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children, adolescents and young adults with sickle cell disease

Exclusion criteria

Exclusion Criteria:

  • other inherited anemia
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
400 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Groups and cohorts

  • Children, adolescents and young adults with sickle cell disease

    We will start with those who were/are following at Hematology Oncology and BMT Unit, Children's Hospital, Ain Shams University

06

What researchers measure

Primary outcomes

  1. Institutional database

    To create databases and institutional registry for managing the clinical data

    Time frame: 2 years

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Jan 2027, 33 months after the start.

Of 130 non-industry observational studies under Anemia, Sickle Cell, half reached primary completion within 48 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 109. This study's planned 33 months is below that.

Counting every sponsor, half of 139 studies reached it within 49 months; a quarter within 24 and three quarters within 109.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2026
First posted
Sep 2, 2026
StartActual
Mar 17, 2024
Primary completionEst.
Jan 1, 2027
CompletionEst.
Mar 1, 2027
Last update
Sep 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07800247
Responsible party
Fatma Soliman Elsayed Ebeid, MD (Prof of Pediatrics, Deputy Director of Ain Shams University Research Institute, Director of Ain Shams Clinical Research Center, Ain Shams University, Egypt, Ain Shams University) — Principal investigator
First posted
Sep 2, 2026
Start date
Mar 17, 2024
Primary completion
Jan 1, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Sep 2, 2026

Study contacts

Dr. Fatma Ebeid Ebeid
Contact
FatmaEbeid@med.asu.edu.eg
+20 109 5569596

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion